Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • kuintzlr
    Junior Member
    • Jan 2014
    • 2

    Cufflinks/Cuffdiff isoforms.fpkm_tracking output: greater FPKMs than the upper bound

    I have run several different data sets through the Tuxedo pipeline, but have just noticed that the isoforms.fpkm_tracking files are all messed up in the FPKM columns. According to the Cufflinks manpage, columns 10-12 of all the tracking files are defined as follows:

    10 q0_FPKM 8.01089 FPKM of the object in sample 0
    11 q0_FPKM_lo 7.03583 the lower bound of the 95% confidence interval on the FPKM of the object in sample 0
    12 q0_FPKM_hi 8.98595 the upper bound of the 95% confidence interval on the FPKM of the object in sample 0

    However, in my files, MANY column 10 FPKM values are several orders of magnitude higher than column 12, FKPM_conf_hi, which is the upper bound. Has anyone else noticed this in their files? I cannot find any explanation for this, and like I said, all of these files, even from different datasets and different experiments, show the same phenomenon.

    I am using TopHat v2.0.9, cufflinks v2.1.1.

    I have attached a pdf image of a scatterplot to visualize these differences, because it seems that this error is correlated to fragment length. On the y-axis is the difference FKPM(column 10 above)-FPKM_conf_hi(column 12, upper bound). This SHOULD be negative. All points above the x axis are erroneous.
    The x-axis is fragment length (Column 8 of isoforms.fpkm_tracking). You can see that this error seldom occurs at higher fragment lengths.

    Please help!
    Attached Files
  • Dario1984
    Senior Member
    • Jun 2011
    • 166

    #2
    It's a known problem. The confidence intervals are calculated wrongly. The estimate is correct, though. The next version of Cufflinks will have this fixed.

    Comment

    • kuintzlr
      Junior Member
      • Jan 2014
      • 2

      #3
      Thank you Dario1984. Where did you find this information?

      Comment

      • Dario1984
        Senior Member
        • Jun 2011
        • 166

        #4
        I read it on a blog. The new version of Cufflinks is now released. You can run your analysis again.

        Comment

        Latest Articles

        Collapse

        • mylaser
          Reply to Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by mylaser
          Kheloyaar Login: Easy Steps to Access Your Gaming Account
          One of the most searched queries today is Kheloyaar login because users want quick and secure account access.
          The process is straightforward:
          Visit the official gaming platform.
          Open the login section.
          Enter your registered details.
          Complete the required verification.
          Access your gaming dashboard.
          The Kheloyaar login process is designed to save time while maintaining account security for every...
          Today, 07:46 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 10:26 AM
        0 responses
        13 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        16 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-07-2026, 11:05 AM
        0 responses
        33 views
        0 reactions
        Last Post SEQadmin2  
        Working...